Inozyme Pharma, Inc. (INZY) has a market capitalization of $258.25M and trades at $4.00. The 52-week range is 0.721-6.24.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.5, Earnings Per Share (EPS) of $-1.62.
The stock has a beta of 2.29, operates in the Healthcare sector.
